tiprankstipranks
Advertisement
Advertisement

BSEM Stock Latest News

BioStem Technologies Balances Bold Acquisition With Strain
Company AnnouncementsBioStem Technologies Balances Bold Acquisition With Strain
13d ago
BSEM
BSEM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
BSEM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
19d ago
BSEM
BioStem’s Diabetic Foot Ulcer Trial Reaches Completion: What Investors Should Watch Next
PremiumCompany Announcements
BioStem’s Diabetic Foot Ulcer Trial Reaches Completion: What Investors Should Watch Next
3M ago
BSEM
BioStem Technologies Q3 Earnings Call Highlights Resilience
PremiumCompany Announcements
BioStem Technologies Q3 Earnings Call Highlights Resilience
5M ago
BSEM
BioStem Technologies Reports Q3 2025 Financial Results
PremiumCompany Announcements
BioStem Technologies Reports Q3 2025 Financial Results
5M ago
BSEM
BSEM Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsBSEM Upcoming Earnings Report: What to Expect?
5M ago
BSEM
BioStem Technologies’ Promising Clinical Trial for Venous Leg Ulcers: A Potential Game-Changer
Premium
Company Announcements
BioStem Technologies’ Promising Clinical Trial for Venous Leg Ulcers: A Potential Game-Changer
5M ago
BSEM
BioStem Technologies’ Promising Study on Diabetic Foot Ulcers: A Potential Game-Changer
Premium
Company Announcements
BioStem Technologies’ Promising Study on Diabetic Foot Ulcers: A Potential Game-Changer
5M ago
BSEM
BioStem Technologies’ Earnings Call: Mixed Sentiment Amid Growth Plans
PremiumCompany Announcements
BioStem Technologies’ Earnings Call: Mixed Sentiment Amid Growth Plans
7M ago
BSEM
BioStem Technologies Reports Q2 2025 Financial Results
PremiumCompany Announcements
BioStem Technologies Reports Q2 2025 Financial Results
8M ago
BSEM
BioStem Technologies’ Innovative Approach to Healing Venous Leg Ulcers: A Clinical Study Update
PremiumCompany Announcements
BioStem Technologies’ Innovative Approach to Healing Venous Leg Ulcers: A Clinical Study Update
9M ago
BSEM
BioStem’s BR-AM Trial: A Potential Game-Changer for Diabetic Foot Ulcers
PremiumCompany Announcements
BioStem’s BR-AM Trial: A Potential Game-Changer for Diabetic Foot Ulcers
9M ago
BSEM
BioStem Technologies Advances Diabetic Foot Ulcer Treatment with BR-AM Study
PremiumCompany AnnouncementsBioStem Technologies Advances Diabetic Foot Ulcer Treatment with BR-AM Study
9M ago
BSEM
BioStem Technologies’ Promising Study on Venous Leg Ulcer Treatment
Premium
Company Announcements
BioStem Technologies’ Promising Study on Venous Leg Ulcer Treatment
9M ago
BSEM
BioStem Technologies’ Promising Clinical Study on Venous Leg Ulcers
Premium
Company Announcements
BioStem Technologies’ Promising Clinical Study on Venous Leg Ulcers
10M ago
BSEM
BioStem Technologies’ Promising Clinical Study on Venous Leg Ulcers
PremiumCompany Announcements
BioStem Technologies’ Promising Clinical Study on Venous Leg Ulcers
10M ago
BSEM
BioStem’s Innovative Approach to Diabetic Foot Ulcers: A Clinical Study Update
PremiumCompany Announcements
BioStem’s Innovative Approach to Diabetic Foot Ulcers: A Clinical Study Update
10M ago
BSEM
BioStem Technologies’ Promising Study on Venous Leg Ulcer Treatment
PremiumCompany Announcements
BioStem Technologies’ Promising Study on Venous Leg Ulcer Treatment
10M ago
BSEM
BioStem Technologies’ Promising Trial for Diabetic Foot Ulcers: A Potential Game-Changer
PremiumCompany Announcements
BioStem Technologies’ Promising Trial for Diabetic Foot Ulcers: A Potential Game-Changer
10M ago
BSEM
BioStem Technologies Reports Record Revenue and Profitability
PremiumCompany AnnouncementsBioStem Technologies Reports Record Revenue and Profitability
11M ago
BSEM
BioStem Technologies Reports Strong Q1 2025 Growth
Premium
Company Announcements
BioStem Technologies Reports Strong Q1 2025 Growth
11M ago
BSEM
BioStem Technologies Reports Record Revenue in Earnings Call
Premium
Company Announcements
BioStem Technologies Reports Record Revenue in Earnings Call
12M ago
BSEM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >